Literature DB >> 17344323

Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.

Patrick W Serruys1, Joost Daemen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17344323     DOI： 10.1161/CIRCULATIONAHA.106.666826

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  Clinical performance of a novel ultrathin strut, low-dose, sirolimus-eluting stent with abluminal-only biodegradable polymeric coating for patients undergoing percutaneous coronary intervention in the daily practice.

Authors:  Guy F A Prado; Expedito E Ribeiro; Pedro H M C Melo; Fabio A Pinton; Antonio Esteves-Filho; Celso K Takimura; Jose Mariani; Luiz J Kajita; Gilberto Marchiori; Breno de Alencar Araripe Falcao; Micheli Z Galon; Paulo R Soares; Silvio Zalc; Pedro A Lemos
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

2.  The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I) : the one-year clinical follow-up.

Authors:  Martin Unverdorben; Ralf Degenhardt; Marcus Wiemer; Dieter Horstkotte; Henrik Schneider; Christoph Nienaber; Wolfgang Bocksch; Michael Gross; Michael Boxberger; Christian Vallbracht
Journal:  Clin Res Cardiol       Date:  2007-08-23       Impact factor: 5.460

3.  Intermediate term outcomes with bifurcation coronary stenting using the paclitaxel drug-eluting stent: a single centre experience.

Authors:  Nicolas W Shammas; Eric J Dippel; Gail A Shammas; Leslie Farland; Stephanie Brosius; Michael Jerin; Amber Avila; Lauren Gehbauer; Matthew Winter; Penny Stoakes; Jeannette Byrd; Peter Sharis; Jon Robken
Journal:  Int J Angiol       Date:  2008

4.  [Coronary intervention. 2012 update].

Authors:  H Rittger; M Arnold; M Schmid; S Zimmermann; W G Daniel
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

5.  The impact of severe distal left main disease on target lesion revascularization in patients with trifurcating coronary artery disease receiving the paclitaxel drug-eluting stent.

Authors:  Nicolas W Shammas; Gail A Shammas; Michael Jerin
Journal:  Int J Angiol       Date:  2010

6.  Surface chemistry and polymer film thickness effects on endothelial cell adhesion and proliferation.

Authors:  Dhiman Bhattacharyya; Hao Xu; Rajendra R Deshmukh; Richard B Timmons; Kytai T Nguyen
Journal:  J Biomed Mater Res A       Date:  2010-08       Impact factor: 4.396

7.  Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.

Authors:  Young-Guk Ko; Dong-Min Kim; Jin Man Cho; So Yeon Choi; Jung Han Yoon; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-08       Impact factor: 2.357

8.  Role of E2F1-cyclin E1-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs.

Authors:  Barbara Dapas; Rossella Farra; Mario Grassi; Carlo Giansante; Nicola Fiotti; Laura Uxa; Giuseppe Rainaldi; Alberto Mercatanti; Alfonso Colombatti; Paola Spessotto; Valentina Lacovich; Gianfranco Guarnieri; Gabriele Grassi
Journal:  Mol Med       Date:  2009-06-25       Impact factor: 6.354

9.  Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

Authors:  David J Malenka; Aaron V Kaplan; F Lee Lucas; Sandra M Sharp; Jonathan S Skinner
Journal:  JAMA       Date:  2008-06-25       Impact factor: 56.272

Review 10.  Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention.

Authors:  Morgane Ethgen; Isabelle Boutron; Philippe Gabriel Steg; Carine Roy; Philippe Ravaud
Journal:  Trials       Date:  2009-05-04       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.